Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LINE Lineage

休市中 03-20 16:00:00 EDT

35.13

-1.62

-4.41%

盘后35.13

+0.000.00%

17:41 EDT

最高37.03	最低34.36	成交量151.06万
今开37.03	昨收36.75	日振幅7.28%
总市值79.77亿	流通市值20.25亿	总股本2.27亿
成交额5,343万	换手率2.62%	流通股本5,764万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":35.13,"timestamp":1774036800000,"preClose":36.75,"halted":0,"volume":1510570,"hourTrading":{"tag":"盘后","latestPrice":35.13,"preClose":35.13,"latestTime":"17:41 EDT","volume":114303,"amount":4015478.14996,"timestamp":1774042893741,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.044081632653061156,"floatShares":57642784,"shares":227080326,"eps":-0.43,"marketStatus":"休市中","change":-1.62,"latestTime":"03-20 16:00:00 EDT","open":37.03,"high":37.03,"low":34.355,"amount":53432320.1053,"amplitude":0.072789,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.43,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":36.75,"dividendRate":0.060046,"preHourTrading":{"tag":"盘前","latestPrice":36.9,"preClose":36.75,"latestTime":"09:28 EDT","volume":704,"amount":25986.283136,"timestamp":1774013281025,"change":0.15,"changeRate":0.004082,"amplitude":0.019592},"postHourTrading":{"tag":"盘后","latestPrice":35.13,"preClose":35.13,"latestTime":"17:41 EDT","volume":114303,"amount":4015478.14996,"timestamp":1774042893741,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.0356629625421654,"impliedVol":0.6158,"impliedVolPercentile":0.9841},"requestUrl":"/m/hq/s/LINE","defaultTab":"news","newsList":[{"id":"2618390361","title":"IXCells达成iPSC细胞系交付里程碑IXCells Reaches iPSC Line Delivery Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2618390361","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618390361?lang=zh_cn&edition=full","pubTime":"2026-03-12 13:51","pubTimestamp":1773294660,"startTime":"0","endTime":"0","summary":"此次合作利用了iXCells的iPSCore平台，该平台能够大规模生成经过充分鉴定的患者来源iPSC细胞系，以支持新型疗法的发现与开发。The platform supports drug discovery by enabling the creation, characterization and delivery of validated iPSC lines derived from diverse patient cohorts. iPSCore is delivering nearly 200 lines per month, with a reprogramming success rate exceeding 98%, and built-in cell banking at each stage to ensure continuity and mitigate risk.该平台通过支持创建、表征和交付源自不同患者群体的经过验证的iPSC细胞系来助力药物发现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031213531597aee702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031213531597aee702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2618611853","title":"Lineage Cell Therapeutics, Inc.2025财年实现净利润-63.53百万美元，同比减少241.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618611853","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618611853?lang=zh_cn&edition=full","pubTime":"2026-03-09 00:01","pubTimestamp":1772985680,"startTime":"0","endTime":"0","summary":"3月9日，Lineage Cell Therapeutics, Inc.公布财报，公告显示公司2025财年净利润为-63.53百万美元，同比减少241.38%；其中营业收入为14.56百万美元，同比增加53.26%，每股基本收益为-0.28美元。从资产负债表来看，Lineage Cell Therapeutics, Inc.总负债69.24百万美元，其中短期债务853000.00美元，资产负债比为0.02，流动比率为5.21。机构评级：截至2026年3月9日，当前有5家机构对Lineage Cell Therapeutics, Inc.目标价做出预测，其中目标均价为4.60美元，其中最低目标价为3.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000152a4587951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000152a4587951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LENZ"],"gpt_icon":0},{"id":"2617583816","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.43%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617583816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617583816?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:31","pubTimestamp":1772807502,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日22时31分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨5.43%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。其相关个股中，Day One Biopharmaceuticals, Inc.、Solid Biosciences Inc.、Moolec Science Sa C/Wts 30/01/2028涨幅较大，Day One Biopharmaceuticals, Inc.、Quince Therapeutics, Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为26.07%、19.67%、16.48%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Contineum Therapeutics, Inc.、Cartesian Therapeutics, Inc.，振幅分别为24.36%、9.30%、7.69%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306223142954392bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306223142954392bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4539","LENZ","BK4224","LINE","BK4139","BK4007"],"gpt_icon":0},{"id":"1189522376","title":"财报前瞻 ｜Lineage本季度营收预计增3.15%，机构观点偏看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1189522376","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189522376?lang=zh_cn&edition=full","pubTime":"2026-02-18 11:15","pubTimestamp":1771384533,"startTime":"0","endTime":"0","summary":"Lineage将于2026年02月25日发布最新季度业绩，市场关注营收小幅增长与利润修复路径、以及各业务线对盈利的边际贡献。市场一致预期，本季度Lineage营收约13.78亿美元，同比增长3.15%；调整后每股收益为-0.12美元，同比下降235.85%。目前一致预期未披露毛利率与净利润或净利率的具体口径，相关预测不予展示。上季度公司实现营收13.77亿美元，同比增长3.15%；毛利率32.32%；归属于母公司净利润-1.00亿美元，净利率-7.26%；调整后每股收益-0.36美元，同比改善85.25%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Lineage本季度营收预计增3.15%，机构观点偏看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"gpt_icon":0},{"id":"2611909593","title":"Lineage, Inc.盘中异动 急速下跌5.04%报36.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611909593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611909593?lang=zh_cn&edition=full","pubTime":"2026-02-13 01:14","pubTimestamp":1770916466,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日01时14分，Lineage, Inc.股票出现波动，股价急速下跌5.04%。截至发稿，该股报36.92美元/股，成交量27.9623万股，换手率0.12%，振幅6.64%。Lineage, Inc.股票所在的房地产信托行业中，整体涨幅为3.42%。Lineage, Inc.公司简介：Lineage Inc是一家温控仓库房地产投资信托公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213011426a49d4b60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213011426a49d4b60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2610869636","title":"颜值更高：Lineage OS 23.2发布，适配安卓最新设计语言","url":"https://stock-news.laohu8.com/highlight/detail?id=2610869636","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610869636?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:54","pubTimestamp":1770688475,"startTime":"0","endTime":"0","summary":"IT之家 2 月 10 日消息，Lineage OS 团队于 2 月 8 日发布公告，推出 23.2 版本更新，全面引入了安卓最新的 Material 3 Expressive 设计语言，与 Google Pixel 系列及 AOSP保持视觉同步。在稳定性方面，开发团队确认 Lineage OS 23.2 的表现已与此前的 23.0 版本持平，完全具备日常使用的成熟度。同时，随着新版本的推出，旧版 Lineage OS 21 将不再接受新设备的适配申请，开发资源将向新版本倾斜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8qcoUV2vOtN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2602560565","title":"一汽 - 大众探岳 L PHEV 申报！双外观可选，插混动力续航亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2602560565","media":"ITBEAR科技资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602560565?lang=zh_cn&edition=full","pubTime":"2026-01-12 00:57","pubTimestamp":1768150645,"startTime":"0","endTime":"0","summary":"工信部最新披露的信息显示，一汽-大众旗下全新插电混动中型SUV探岳L PHEV已完成申报流程。根据不同配置版本，新车在工信部测试中取得113公里至115公里的纯电续航里程。车身尺寸方面，常规版长宽高分别为4684/1853/1677毫米，R-Line运动版则增至4695/1866/1678毫米，两版本轴距统一为2791毫米。申报图显示，新车提供多达4种轮毂样式及丰富的外观选装件，包括前照灯组、前后保险杠、摄像头等部件均可个性化定制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112005937a4b753bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112005937a4b753bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2602085933","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘快速下跌5.19%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602085933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602085933?lang=zh_cn&edition=full","pubTime":"2026-01-09 03:55","pubTimestamp":1767902116,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日03时55分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下跌5.19%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.25%。其相关个股中，Enliven Therapeutics, Inc.、Century Therapeutics, Inc.、Moonlake Immunotherapeutics涨幅较大，Pmgc Holdings Inc.、Acrivon Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为526.28%、127.45%、81.48%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Enliven Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为146.48%、59.43%、52.53%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109035516a70420d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109035516a70420d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4139","BK4224","BK4007","BK4539","LENZ","LCTX"],"gpt_icon":0},{"id":"2577430291","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌5.15%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577430291","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577430291?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:25","pubTimestamp":1761143102,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时25分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅跳水5.15%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022222503a6c83615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022222503a6c83615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4224","BK4539","LCTX","LINE","BK4139","LENZ"],"gpt_icon":0},{"id":"2569475758","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569475758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569475758?lang=zh_cn&edition=full","pubTime":"2025-09-23 01:16","pubTimestamp":1758561418,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日01时16分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.56%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.较为活跃，换手率分别为3187.70%、158.30%、67.32%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Kodiak Sciences Inc，振幅分别为144.19%、86.84%、43.65%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923011658a43cdab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923011658a43cdab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4224","BK4007","BK4139","LCTX","LENZ","LINE"],"gpt_icon":0},{"id":"1166565406","title":"Lineage Cell Therapeutics 2024年第四季度GAAP每股收益$(0.02) 超过预期$(0.03)，销售额$2.900百万 超预期$1.621百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1166565406","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166565406?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:08","pubTimestamp":1741637306,"startTime":"0","endTime":"0","summary":"公司报告季度销售额$2.900百万，超过了分析师共识预估的$1.621百万，提高了78.88%。与去年同期的销售额$2.100百万相比，这一数字增长了38.10%。以上内容来自Benzinga Earnings专栏，原文如下：$Lineage$ Cell $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 33.33 percent. This is a 33.33 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $2.900 million which beat the analyst consensus estimate of $1.621 million by 78.88 percent.  This is a 38.10 percent","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LCTX","LINE"],"gpt_icon":0},{"id":"2518220660","title":"Scotiabank：维持Lineage(LINE.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至74.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220660","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220660?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:02","pubTimestamp":1741629758,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Lineage(LINE.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至74.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11020248641749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"gpt_icon":0},{"id":"2518527621","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速上涨7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518527621?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:39","pubTimestamp":1741613947,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨7.06%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为487.59%、74.68%、56.14%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为34.57%、28.59%、25.35%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","LCTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2517160017","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.53%报0.548美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517160017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517160017?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:51","pubTimestamp":1741279881,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时51分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.53%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LENZ","LCTX","BK4139"],"gpt_icon":0},{"id":"2517028306","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517028306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517028306?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:32","pubTimestamp":1741109577,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时32分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LCTX","LINE","BK4139","LENZ"],"gpt_icon":0},{"id":"2516344637","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌5.24%报0.532美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516344637?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:05","pubTimestamp":1741014302,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时05分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.24%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1039.63%、125.32%、100.95%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4139","BK4224","LENZ","LCTX"],"gpt_icon":0},{"id":"2514833037","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌7.13%报0.582美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514833037?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:48","pubTimestamp":1740689324,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时48分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速跳水7.13%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1949.46%、414.29%、197.51%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044844abdfc11f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044844abdfc11f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","BK4139","BK4224","LENZ"],"gpt_icon":0},{"id":"1123042009","title":"异动解读 | 机构下调目标价,Lineage股价盘中大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123042009","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123042009?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:46","pubTimestamp":1740682013,"startTime":"0","endTime":"0","summary":"Lineage(LINE.US)今日盘中股价出现大幅波动,最高上涨5.21%。引起市场关注的原因是,分析机构Piper Sandler对该公司的投资评级进行了调整。\n\nPiper Sandler维持了Lineage的\"增持\"评级,但将目标价从90美元大幅下调至75美元。股价波动可能与市场对该调整的反应有关。\n\nLineage是一家房地产投资信托公司,为客户提供端到端的供应链服务,包括冷藏仓储、运输代理等。机构调低目标价或许意味着对该公司前景的担忧,但仍维持增持评级,也说明该公司未来仍有较大增长空间。具体原因有待进一步观察和分析。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 机构下调目标价,Lineage股价盘中大涨5.21%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LINE"],"gpt_icon":0},{"id":"2514336753","title":"Lineage, Inc.盘中异动 快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514336753?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:40","pubTimestamp":1740681645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时40分，Lineage, Inc.股票出现波动，股价急速上涨5.16%。Lineage, Inc.股票所在的房地产信托行业中，整体涨幅为0.52%。其相关个股中，Generation Income Properties Inc C/Wts 、Medical Properties Trust, Inc.、Postal Realty Trust, Inc.涨幅较大，Wheeler Real Estate Investment Trust, Inc.、Orchid Island Capital, Inc.、Medical Properties Trust, Inc.较为活跃，换手率分别为7.83%、2.84%、2.78%，振幅较大的相关个股有Generation Income Properties Inc C/Wts 、Service Properties Trust - Shares Of Beneficial Interest、Power Reit ，振幅分别为192.70%、17.29%、14.40%。Lineage, Inc.公司简介：Lineage Inc是一家房地产投资信托。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022802404598953ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022802404598953ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2514836593","title":"Baird：维持Lineage(LINE.US)评级，由优于大市调整至优于大市评级, 目标价由76.00美元调整至70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514836593","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514836593?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:22","pubTimestamp":1740666171,"startTime":"0","endTime":"0","summary":"Baird：维持Lineage(LINE.US)评级，由优于大市调整至优于大市评级, 目标价由76.00美元调整至70.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27222248438483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onelineage.com;ir.onelineage.com","stockEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0404},{"period":"3month","weight":0.0293},{"period":"6month","weight":-0.13},{"period":"1year","weight":-0.4174},{"period":"ytd","weight":0.0037}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage, Inc.于2017年在马里兰州成立，是全球最大的温控仓储房地产投资信托基金（REIT）。公司拥有现代化且战略布局合理的物业网络，旨在为温控供应链中的多元化客户提供无缝衔接、技术赋能的客户体验。截至2025年12月31日，Lineage已建立起一个互联互通的全球仓储网络，涵盖501个仓库，总面积约8800万平方英尺，总容量达31亿立方英尺，主要分布在人口密集的配送中心市场。公司拥有稳定且多元化的客户群体，包括来自业内一些最大的食品零售商、制造商、加工商和食品服务分销商的11000多家客户。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.009942},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.051794},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.047075},{"month":4,"riseRate":0.909091,"avgChangeRate":0.072457},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.085175},{"month":6,"riseRate":0.7,"avgChangeRate":0.017118},{"month":7,"riseRate":0.6,"avgChangeRate":-0.034691},{"month":8,"riseRate":0.2,"avgChangeRate":-0.040778},{"month":9,"riseRate":0.4,"avgChangeRate":-0.041279},{"month":10,"riseRate":0.7,"avgChangeRate":0.025106},{"month":11,"riseRate":0.4,"avgChangeRate":-0.07115},{"month":12,"riseRate":0.6,"avgChangeRate":-0.044918}],"exchange":"NASDAQ","name":"Lineage","nameEN":"Lineage"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage,LINE,Lineage股票,Lineage股票老虎,Lineage股票老虎国际,Lineage行情,Lineage股票行情,Lineage股价,Lineage股市,Lineage股票价格,Lineage股票交易,Lineage股票购买,Lineage股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}